Talazoparib in Combination With Enzalutamide Improves OS in mCRPC
FDA Awards RMAT Designation to NXC-201 for Relapsed/Refractory AL Amyloidosis
2024 FDA Approvals in Breast, Gynecologic, and Other Solid Tumors Represent Key Steps Forward
Oncology Experts Preview Top Abstracts From 2025 ASCO GU